Fitch Margaret, Pang Kittie, Ouellet Veronique, Loiselle Carmen, Alibhai Shabbir, Chevalier Simone, Drachenberg Darrel E, Finelli Antonio, Lattouf Jean-Baptiste, Sutcliffe Simon, So Alan, Tanguay Simon, Saad Fred, Mes-Masson Anne-Marie
Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada.
Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada.
BMC Urol. 2017 Oct 27;17(1):98. doi: 10.1186/s12894-017-0290-7.
In prostate cancer, men diagnosed with low risk disease may be monitored through an active surveillance. This research explored the perspectives of men with prostate cancer regarding their decision-making process for active surveillance to identify factors that influence their decision and assist health professionals in having conversations about this option.
Focus group interviews (n = 7) were held in several Canadian cities with men (N = 52) diagnosed with prostate cancer and eligible for active surveillance. The men's viewpoints were captured regarding their understanding of active surveillance, the factors that influenced their decision, and their experience with the approach. A content and theme analysis was performed on the verbatim transcripts from the sessions.
Patients described their concerns of living with their disease without intervention, but were reassured by the close monitoring under AS while avoiding harmful side effects associated with treatments. Conversations with their doctor and how AS was described were cited as key influences in their decision, in addition to availability of information on treatment options, distrust in the health system, personality, experiences and opinions of others, and personal perspectives on quality of life.
Men require a thorough explanation on AS as a safe and valid option, as well as guidance towards supportive resources in their decision-making.
在前列腺癌患者中，被诊断为低风险疾病的男性可能通过主动监测进行观察。本研究探讨了前列腺癌男性患者对于主动监测决策过程的观点，以确定影响其决策的因素，并帮助医疗专业人员就该选择进行沟通。
在加拿大的几个城市对被诊断为前列腺癌且适合主动监测的男性（N = 52）进行了焦点小组访谈（n = 7）。收集了这些男性对于主动监测的理解、影响其决策的因素以及他们对该方法体验的观点。对访谈的逐字记录进行了内容和主题分析。
患者描述了他们对不进行干预而患有疾病的担忧，但在主动监测的密切监测下感到安心，同时避免了与治疗相关的有害副作用。除了治疗选择信息的可获得性、对医疗系统的不信任、个性、他人的经历和意见以及对生活质量的个人看法外，与医生的交谈以及主动监测的描述方式被认为是他们决策的关键影响因素。
男性需要对主动监测作为一种安全有效的选择进行全面解释，以及在其决策过程中提供支持资源的指导。
